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ABSTRACT
Objective To use a computational approach to
investigate the cellular and extracellular matrix changes
that occur with age in the knee joints of mice.
Methods Knee joints from an inbred C57/BL1/6 (ICRFa)
mouse colony were harvested at 3–30 months of age.
Sections were stained with H&E, Safranin-O, Picro-sirius
red and antibodies to matrix metalloproteinase-13
(MMP-13), nitrotyrosine, LC-3B, Bcl-2, and cleaved type II
collagen used for immunohistochemistry. Based on this
and other data from the literature, a computer simulation
model was built using the Systems Biology Markup
Language using an iterative approach of data analysis
and modelling. Individual parameters were subsequently
altered to assess their effect on the model.
Results A progressive loss of cartilage matrix occurred
with age. Nitrotyrosine, MMP-13 and anaplastic
lymphoma kinase (ALK1) staining in cartilage increased
with age with a concomitant decrease in LC-3B and
Bcl-2. Stochastic simulations from the computational
model showed a good agreement with these data, once
transforming growth factor-β signalling via ALK1/ALK5
receptors was included. Oxidative stress and the
interleukin 1 pathway were identified as key factors in
driving the cartilage breakdown associated with ageing.
Conclusions A progressive loss of cartilage matrix and
cellularity occurs with age. This is accompanied with
increased levels of oxidative stress, apoptosis and
MMP-13 and a decrease in chondrocyte autophagy.
These changes explain the marked predisposition of joints
to develop osteoarthritis with age. Computational
modelling provides useful insights into the underlying
mechanisms involved in age-related changes in
musculoskeletal tissues.
INTRODUCTION
Cartilage is a unique tissue in which the sole cell
type, the chondrocyte, precisely arranges extracellu-
lar matrix (ECM) macromolecules, which mainly
consists of type II collagen and aggrecan, to under-
pin normal tissue function and architecture. In
normal cartilage, chondrocytes maintain a dynamic
equilibrium with a balance between ECM produc-
tion and its proteolytic breakdown. Chondrocytes
secrete cartilage-degrading enzymes such as collage-
nases, members of the matrix metalloproteinase
(MMP) family which are the most effective proteo-
lytic enzymes at cleaving native collagen during the
loss of cartilage that characterises osteoarthritis
(OA).1 OA is characterised by a disruption of the
articular cartilage surface2 and MMP-13 is a key
mediator within OA cartilage that plays a significant
role in cartilage collagen breakdown.3 4
Multiple genetic and environmental factors are
implicated in the development of OA but ageing is the
most important risk factor.5 Avariety of changes occur
in cartilage with age that include an accumulation of
oxidative stress, DNA and protein damage, overpro-
duction of proteolytic enzymes by chondrocytes, a
loss of cartilage matrix and a decrease in the ability of
chondrocytes to function normally and to survive.6 7
Autophagy is protective in normal cartilage and loss of
this mechanism with age increases cell death asso-
ciated with OA.8 9 Apoptosis also contributes to the
loss of cellularity and cartilage degeneration in OA
with a central role for the caspase proteolytic
cascade.10 However, the relationship between these
mediators, how they contribute to age-related changes
in cartilage and the cartilage degeneration seen in
disease remains to be determined.
The aim of this study was to rigorously assess the
changes and sequence of events that occur within
joints taken from mice aged from 3 to 30 months
with respect to morphology, cellular changes, matrix
loss and the presence of relevant mediators with a
view to identifying mechanisms that predispose aged
cartilage to degeneration and the development of OA.
Combined with this, we have used computational
modelling to aid our understanding of the age-related
processes11 by integrating the different mechanisms
of ageing identified in the histological study to
provide a robust and testable model of the underlying
mechanisms and the interplay between them.
METHODS
Animals
Mice were from a long-established colony of the
inbred C57/BL1/6 (ICRFa) mouse strain selectively
bred for longevity.12 Both knee joints were
collected from male mice aged 3–30 months (four
mice per group). Mice were housed in standard
cages in groups of four to six which did not change
from weaning. Mice were provided with ad libitum
food and water and housed at 20±2°C under a
12 h light/12 h dark photoperiod. Procedures were
performed in accordance with the UK Home Office
regulations.
Reagents
Polyclonal antibodies to MMP-13 were raised in
rabbit.13 Anti-type-II collagen collagenase cleavage
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site neoepitope antibody (COL2-1/4N1) was a gift from E. Lee
(Shriner’s Hospital for Children, Montreal, Canada).14
Anti-3-nitrotyrosine antibody (ab61392) was from Abcam,
Cambridge, UK; anti-LC-3B antibody (L7543) was from
Sigma-Aldrich, Poole UK; anti-Bcl-2 (PC68) and anti-Bax (PC66)
rabbit polyclonal antibody were purchased from Calbiochem,
Germany; anti-anaplastic lymphoma kinase (ALK1) (C-20:
SC-19547) and transforming growth factor-β (TGF-δ) RI(V-22;
sc-398) were purchased from SANTA CRUZ Biotechnology.
VECTASTAIN Elite ABC kits PK 6102 and 6106 were from
Vector Laboratories (Burlingame, California, USA). All other
reagents were commercially available analytical grade obtained
from Sigma-Aldrich.13
Histological assessment of OA changes with age
in mice knee joints
Histology was performed as described.13 Knee joints were fixed
in 4% paraformaldehyde solution for 24 h then decalcified in
10% (w/v) EDTA in phosphate buffer for 10 days. Joints were
embedded in paraffin and frontal sections (5 mm) cut across
each entire joint, followed by staining with Weigert’s haema-
toxylin and Safranin-O/Fast Green. Multiple sections of each
entire joint were graded using Osteoarthritis Research Society
International scoring system, by two closely correlating scorers
blinded to the specimens.15 The higher scores for each joint
were used to populate data samples for each joint.
Immunohistochemistry
Sections were analysed using immunohistochemistry as
described.13 Formalin-fixed paraffin sections were deparaffi-
nised, rehydrated and treated with 0.05% (w/v) trypsin (ll-S,
Sigma) at 37°C for 20–30 min. Sections were blocked (1.5%
normal sheep serum) for 30 min, and then incubated with
primary antibodies at the dilutions stated: anti-COL2-1/4N1
(1:1500), anti-MMP-13 (1:250), anti-nitrotyrosine (1:2000),
Bcl-2 (1:40), anti-ALK1 (1:100), anti-ALK5 (1:200), anti-LC-3B
(1:150 ) and normal rabbit immunoglobulin G (as an isotype-
matched control) overnight at 4°C. After sequential incubations
with biotinylated secondary antibody and avidin–biotin complex
using the Vectastain kit 6101 (Vector, Peterborough), signal was
developed using 3,30-diaminobenzidine tetra-hydrochloride
chromogenic solution (DAKO, Ely, UK) with haematoxylin
counterstaining.13
Quantification of chondrocyte immunostaining
in sections from joints of aged mice
Positively stained chondrocytes in knee articular cartilage from
C57/BL (ICRFa) mice were counted by two blinded observers.
The number of immunopositive cells were counted in each
section and expressed as a percentage of the total number of
cells with a minimum of 100 cells counted each time.
Image and statistical analyses
Images of stained sections were captured using a Leica DMR
microscopy with the Leica DFC310 FX 1.4-megapixel digital
colour camera (Leica Microsystems, Wetzlar, Germany). Student
t test was used for statistical analysis. p Values <0.05 were con-
sidered significant.
Model construction
A computational model was constructed to incorporate the
age-related changes observed in the mouse joints. We included
components that had been directly measured and others known
to be important in ageing. These were chosen as a result of a
literature search on ageing and OA which indicated that key
components included the molecular mechanisms involved in
oxidative stress,16 protein damage,17 accumulation of advanced
glycation end-products,18 autophagy,9 apoptosis,19 nuclear
factor (NF)-κB signalling,20 TGF-β signalling,21 upregulation
and activation of matrix-degrading enzymes22 and cartilage
turnover (figure 1). Because the model is complex, we split it
into five modules: damage, NF-κB, TGF-β/Alk1, TGF-β/Alk5
and autophagy/apoptosis. The model assumptions are given in
the online supplementary file together with full details of all
components and reactions (see online supplementary figures S1–
S5 and tables S1–S6). The model was constructed as a biochem-
ical network using CellDesigner23 and encoded in the Systems
Biology Markup Language.24 Stochastic simulations were per-
formed in COmplex PAthway SImulator25 and on a computer
cluster using code developed by Newcastle University.26 Results
were analysed in R and plotted with the R package ggplot2.27
The model was deposited in BioModels Database28 and assigned
the identifier (MODEL1402200004).
RESULTS
Age-related changes in knee joint morphology
Knee joints from 3-month-old mice showed a smooth and orga-
nised cartilage surface, clear joint space and normal synovium
(figure 2A1, A2). There was progressive loss of joint space and
synovial changes with age. At 30 months, joints showed cartilage
surface discontinuity, vertical fissures to the cartilage/bone inter-
face, substantial loss of articular cartilage in the midline of the
joint and thinning of the subchondral bone (figure 2A3, A4).
Semiquantitative scoring indicated the development of severe
OA in aged mice: joint sections were scored grades 1–2 at
12 months and 5–6 at 24 and 30 months (figure 2B).
There was loss of cellularity in the aged cartilage samples
compared with young mice, and in some joints a significant
increase was observed in synovial hyperplasia by 12 months
(figure 2C1) and there was evidence of localised invasion into
cartilage (figure 2C2). At 30 months, an increase in synovial
blood vessel formation was often observed (figure 2C3), and
sometimes bone fracture was seen where synovial cells appeared
to invade (figure 2C4).
Age-related loss of cartilage matrix proteins
The proteoglycan content of young (3 months) joints
(figure 3A1, A2) showed strong staining. However, with increas-
ing age, there was progressive loss of proteoglycan initially at
the surface. At 30 months, substantial loss of proteoglycan stain-
ing was seen in all zones of cartilage, with staining seen only at
the joint margins and within the meniscus (figure 3A3, A4).
There was progressive loss of collagen with age in articular
cartilage (figure 3B). At 3 months, well-organised lacunae con-
taining chondrocytes were seen in the superficial and middle
zones (figure 3B1, B2). Visualisation by polarised light indicated
a clearly delineated smooth articular surface at 3 months with
the orange-stained collagen fibres orientated in a radial direction
to the cartilage surface with small dark areas indicating high cel-
lularity within the cartilage at the superficial and mid-zone
(figure 3B3). By 30 months (figure 3B4, B5) there was signifi-
cant loss of surface cartilage with complete exposure of the sub-
chondral bone at the midline of the joint plus changes to
the subchondral bone. Any cartilage remaining was confined to
the margins of the joint. Visualisation using polarised light
revealed that at 30 months (figure 3B6) there was substantial
loss of collagen with thinning of the remaining, less organised
collagen fibres.
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Age-related increase in type II collagen cleavage
An increase in the specific MMP-cleavage of collagen type II
was observed with age. Low levels were detected in young cartil-
age (figure 3C1) but this increased with age and by 12 months
increased levels of CII cleavage were observed (figure 3C2)
especially in the middle or deep layers of cartilage and at the
femoral–patellar joint margins. At 24 months, increased
staining was observed with significant loss of articular cartilage
especially on the tibial surface (figure 3C3). Strong staining was
found at isolated sites of erosion at 30 months (figure 3C4, C5)
with most of the cartilage lost from the articular surface and
staining confined to isolated sites of any remaining cartilage
(figure 3C6).
Age-related increase in the expression of MMP-13
MMP-13 is often detected at sites of joint damage and is strongly
implicated in cartilage destruction in OA. We investigated if the
increase in CII cleavage was accompanied by a corresponding
increase in MMP-13. There was little MMP-13 staining in cartil-
age in mice at 3 months; the proportion of MMP-13-positive
chondrocytes increased with time and at 30 months significant
staining of chondrocytes was seen (figure 4A1–A4). Less than
16.00±8.29% of chondrocytes were positive for MMP-13 at
3 months and this rose to 80.00±4.08% of cells at 30 months.
The numbers of MMP-13 positive chondrocytes were signifi-
cantly increased (p<0.01) at 12, 24 and 30 months compared
with 3-month cartilage (figure 4B). These data support a role for
MMP-13 in the observed cleavage of type II collagen in ageing
cartilage (figure 3C).
Age-related increase in the expression of nitrotyrosine
There was little nitrotyrosine staining in cartilage of 3-month-
old mice which progressively increased by 30 months
(figure 4A5–A8). Nitrotyrosine levels were significantly raised
(p=0.0122) as early as 6 months rising to 62±5.88% at
30 months (figure 4B).
Age-related decrease in the expression of LC-3B
Autophagic dysfunction is associated with ageing and human
disease, including OA.29 Figure 4A9–A12 illustrates that high
levels of staining for LC-3B were observed at 3 months but this
was much reduced at 30 months. At 3 months, 82±5.0% of
chondrocytes in the superficial and mid layers of cartilage
expressed LC-3B. This declined with age and by 30 months
only 12.00±5.4% of chondrocytes expressed LC-3B
(figure 4B), suggesting that autophagic dysfunction is indeed
associated with age in cartilage.
Age-related decrease in the expression of Bcl-2
Overexpression of Bcl-2 is known to suppress apoptosis and
high levels of Bcl-2 were found in mouse joint cartilage at
3 months. This was significantly decreased by 30 months
(figure 4A13–A16) suggesting that apoptosis of chondrocytes
also increases with age in murine cartilage. Figure 4B illustrates
that at 3 months 60.50±8.2% of chondrocytes expressed Bcl-2
but this was progressively reduced with age with 32.50±5.3%
and 18.25±3.3% of chondrocytes expressing Bcl-2 at 24 and
30 months, respectively (p<0.01; 30 vs 3 months).
Figure 1 Simplified diagram of the model network showing the main components in the model and how they interact. Advanced glycation end
products (AGEs) are produced spontaneously and activate RAGE receptors. Reactive oxygen species (ROS) are produced by activated RAGE receptors
and damaged protein (DamP) in addition to basal ROS generation via mitochondria (not shown). DamP may be degraded by lysosomes. ROS
increases damage to protein, increases phosphorylation of p38MAPK and activates nuclear factor (NF)-κB. NF-κB upregulates superoxide dismutase
to inhibit ROS, upregulates IκB to inhibit itself and activates interleukin (IL) 1. IL-1 upregulates ADAMTS-5 and matrix metalloproteinase-13
(MMP-13) which degrades aggrecan and collagen II, respectively. MAPK p38 leads to activation of apoptosis. There is also crosstalk between
autophagy and apoptosis via Beclin, Bcl2, Bax and caspases (not shown). Transforming growth factor-β (TGF-β) normally signals via anaplastic
lymphoma kinase (ALK5) to upregulate genes involved in cartilage synthesis. ALK1 signalling increases with age and leads to upregulation of
MMP-13 and so exacerbates cartilage breakdown. Detailed figures showing all the components in the signalling pathways are shown in online
supplementary figures S1–S5.
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Age-related changes in the levels of the TGF-β receptors
ALK1 and ALK5
Because alterations in the levels of ALK1 and ALK5 have been
reported in human OA,21 we investigated the levels of these
TGF-β receptors in aged murine cartilage. High levels of ALK5
were seen at 3 months, which were much reduced by 30 months
(figure 4C1, C2, D). Conversely, ALK1 levels were relatively
low at 3 months but increased with age (figure 4D, C3, C4).
Computational modelling of the age-related
changes in cartilage
The computational model of ageing cartilage (figure 1) was
parameterised to fit the histochemical data. The model output
showed a progressive loss in cartilage collagen (figure 5A)
with a mean percentage loss of 80.5%. The model includes
upregulation of MMP-13 by both the interleukin 1 (IL-1) and
TGF-β/ALK1 pathways and the model output showed an
Figure 2 Age-related changes in the
morphology of mouse knee joints.
Knee joints were collected and stained
with H&E. At 3 months (A1, A2), the
joint surfaces were covered by normal
articular cartilage, but by 30 months, a
profound loss of cartilage was seen
(A3, A4). Semiquantitative scoring of
the joints indicated the development of
severe osteoarthritis in aged mice (B).
No noticeable defects were observed
at 3 and 6 months but sections were
scored grade 1–2 at 12 months and
5–6 at 24 and 30 months. Data are
expressed as the mean±SD. Statistical
significance: **p<0.01 versus the
3-month-old group. In some knee
joints significant lesions were
observed. At 12 months there was
evidence of increased synovial cell
hyperplasia (C1) and evidence of
invasion of synovial cells into the
articular cartilage (C2); top arrow
indicates site of erosion. At 30 months
(C3), blood vessels were observed
(small arrows) within the synovium
and bone fracture caused by synovial
cell invasion (C4) was seen in some
joints. ac, articular cartilage; b, bone;
bm, bone marrow; f, bone fracture;
js, joint space; m, meniscus; mf,
meniscus fracture; ms, muscle; OARSI,
Osteoarthritis Research Society
International; p, pannus; s, synovium;
sh, synovial hyperplasia; tb, trabecular
bone; v, blood vessel. All mice were
male, n=4.
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increase in MMP-13 levels with age (figure 5A). The small,
gradual increase over time was due to IL-1 activation and the
large intermittent peaks of MMP-13 were a result of Runx2
activation via ALK1 signalling. In most simulations, these
peaks occurred more frequently at later time points due to
the increase in the ALK1/ALK5 ratio with age. We calculated
the percentage of ‘simulated cells’ from 500 stochastic simula-
tions that expressed MMP-13 above a basal level of 15
molecules (figure 5B). The model output closely matched the
experimental data (figure 3B).
A gradual decline in lysosome activity (modelled by assuming
that lysosomes require Beclin for activation) and an increase in
damaged protein over time was observed in individual simula-
tions (figure 5C) and the percentage of ‘simulated cells’ expres-
sing activated lysosomes decreased, and damaged proteins
increased with age (figure 5B), similar to the experimental data
Figure 3 Age-related changes in proteoglycan, collagen and matrix metalloproteinase (MMP)-specific collagen cleavage in mouse knee joint
cartilage. Knee joints were sectioned and stained for proteoglycan by Safranin-O, collagen with Sirius Red and immunostained for the
MMP-cleavage site of type II collagen. Strong proteoglycan staining was seen at 3 months (A1,A2) but there was progressive proteoglycan loss with
complete removal of cartilage at the midline of the joint at 30 months (A3,A4). Strong collagen staining was seen in cartilage at 3 months (B1,B2).
Under polarised light (B3) collagen fibres appeared bright yellow or orange with reticular fibres staining green. Collagen was reduced with age in
the superficial and middle zones, and by 30 months, the cartilage was completely removed from the midline of the joint (B4,B5,B6). Little specific
collagen cleavage was seen at 3 months (C1), this was increased at 12 months in the middle and deep layers of cartilage (C2). At 24 months,
increased staining was seen (C3), and by 30 months, almost complete loss of articular cartilage was observed with only small isolated pockets
stained (C4). In some joints increased CII staining was seen at cartilage surfaces (C5) with localised staining at cartilage erosion sites at the margins
of the joint at 30 months (C6). ac, articular cartilage; b, bone; bm, bone marrow; Fe, femur; js, joint space; m, meniscus; Pa, patella;
sb, subchondral bone; tb, trabecular bone. All mice were male, n=4.
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(figure 3B). The model output showed a decline in Bcl-2 levels
with age (data not shown) and the percentage of ‘simulated
cells’ expressing Bcl-2 above a threshold level declined with age
(figure 5B). The model also showed an increase in caspase acti-
vation at later time points (data not shown) suggesting that
levels of apoptosis increase with age.
Computational modelling supports an important role for
oxidative stress and the IL-1 pathway
By varying some of the model parameters, we were able to gain
some insights into which pathways particularly lead to upregula-
tion of MMP-13 and cartilage degradation. To examine the rela-
tive contribution of the IL-1 and TGF-β/ALK1 pathways, we
Figure 4 Age-related changes in matrix metalloproteinase (MMP)-13, nitrotyrosine, LC-3B, Bcl-2, anaplastic lymphoma kinase (ALK5) and ALK1
expression in mouse knee joint articular cartilage. Knee joints were sectioned and immunostained with antibody to MMP-13, nitrotyrosine, LC-3B,
Bcl-2, ALK5 or ALK1 and counterstained with haematoxylin. At 3 months, little staining was seen for MMP-13 but substantial staining was observed
at 30 months (A1–A4). MMP-13 was significantly raised at all time points from 12 months (B). Little staining for nitrotyrosine was seen at 3 months
with increased staining at 30 months (A5–A8). Nitrotyrosine was significantly raised at each age group (B). Strong staining was observed for LC-3B
at 3 months with little staining at 30 months (A9–A12) with LC-3B significantly increased at 3–24 months compared with 30 months (B). Strong
staining of Bcl-2 was seen at 3 months with less staining observed at 30 months (A13–A16) with Bcl-2 significantly higher at 3–12 months
compared with 30 months (B). High levels of ALK5 were present at 3 months but this was not found at 30 months (C1, C2) with ALK5 significantly
lower at 12–30 months compared with 3 months (D). ALK1 was present at low levels at 3 months with higher levels at 30 months in cartilage and
within synovial tissues (C3, C4) with ALK1 significantly higher at 12–30 months compared with 3 months (D). Graphical data (B) are expressed as
the mean±SD. Statistical significance: MMP-13: 12, 24, 30 months versus 3 m, p value<0.01; nitrotyrosine: 6 months versus 3 months, p value
<0.05; 12, 24, 30 months versus 3 months, p value <0.01; LC-3B: 3, 6, 12 and 24 months versus 30 months, p value <0.01; Bcl-2: 3, 6, 12 months
versus 30 months, p value <0.01. All mice were male, n=4.
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inhibited MMP-13 upregulation by each pathway in turn. Total
inhibition of MMP-13 synthesis via the IL-1 pathway led to
lower levels of MMP-13 at later time points and a delay in car-
tilage degradation (figure 6A, B). The intermittent peaks of
MMP-13, due to the TGF-β/ALK1 pathway, accounted for the
early degradation of cartilage. Conversely, total inhibition of
MMP-13 synthesis via the TGF-β/ALK1 pathway led to lower
levels of MMP-13 at early time points but did not prevent the
age-related increase in MMP-13 and the rate of cartilage degrad-
ation was not reduced (figure 6B–C). Because oxidative stress
was an important mechanism included in the model, we exam-
ined the effect of increased reactive oxygen species removal via
superoxide dismutase (SOD). This simulated intervention led to
lower levels of MMP-13 via the IL-1 pathway, especially at late
ages, and cartilage degradation was reduced (figure 6B, D).
DISCUSSION
Ageing is the most significant risk factor for the development of
OA and until recently little has been known of the age-related
changes that occur in cartilage. In this study, we have investigated
the cellular and matrix changes that occur with age in the knee
joints of male mice from an established and well-characterised
aged mouse colony from 3 to 30 months.30 Some of the observed
changes have been documented before, but to date, this is the
first study to carry out multiple measures in a set of tissues from
an aged mouse colony to enable a better understanding of the
interplay between underlying complex mechanisms. We demon-
strated an overall loss of cartilage matrix with evidence of type II
collagen degradation alongside increased levels of MMP-13, the
major collagenase in cartilage turnover, and evidence of increased
levels of products of oxygen radicals with age. Cellular changes
included a decrease in chondrocyte autophagy and a decrease in
a marker indicative of less suppression of cell death via apoptosis.
Moreover, evidence that chondrocyte cell death correlates with
progression of OA in mice31 further supports out findings.
Interestingly, it has also been shown that an increase in apoptosis
in OA is related to a decline in autophagy in concordance with
our analysis.9 Moreover, chondrocyte hypertrophy in OA has
been previously reported, occurring at different times during
disease progression and at different locations.32 Although we did
not assess hypertrophy, such cellular changes will undoubtedly
contribute to the age-related cartilage changes we observed.
Another limitation of the study is that the MMP-13 antibody
stained both pro-MMP-13 and active MMP-13, but we also
showed that collagen cleavage occurred, indicating that MMP-13
must be active.
Figure 5 Simulation results showing changes in collagen II, matrix metalloproteinase-13 (MMP-13) active lysosomes (Lys_A) and damaged protein
(DamP) with age. (A) One randomly chosen simulation run (from 500 stochastic simulations) shows percentage of collagen II and levels of MMP-13.
(B) The percentage of ‘simulated cells’ expressing MMP-13 (>15), DamP (>9), Lys_A (>29) and Bcl2 (>12). (C) One randomly chosen simulation run
(from 500 stochastic simulations) shows levels of DamP and Lys_A. Error bars in B represent a 95% CI of the percentage.
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It has been proposed that young chondrocytes are held in a
quiescent state by TGF-β acting through the receptor ALK5.33
With age the levels of this receptor decrease, the ratio of ALK1
to ALK5 increases, so that TGF-β signals predominantly
through ALK1. As a result, the chondrocytes develop an auto-
lytic phenotype that degrades the surrounding matrix. In young
cartilage TGF-β is protective but with increased signalling
through ALK1, MMP-13 is upregulated and cartilage break-
down ensues. These data fit with the increased expression of
ALK1, MMP-13 and CII cleavage with age found in the current
study and so were incorporated in the computational model.
Loeser34 described a senescent secretory phenotype of chon-
drocytes present in OA induced by random genomic damage
following increased oxidative stress and a decline in proliferative
and synthetic capacity with age. We observed an increase in
nitrotyrosine levels with age, the levels of 8-oxo DNA are
known to increase in OA cartilage, and we have previously
described a decrease in SOD to precede damage in OA cartilage
with resultant dysfunctional mitochondria.35 An increase in
proinflammatory mediators and matrix-degrading enzymes with
an increasingly resistant matrix that all contribute to the devel-
opment of disease have been described;34 we also observed such
changes.
The integrative computational model of the molecular
mechanisms of ageing was able to reproduce the age-related
changes in cartilage and provide a novel way of identifying
interactions between different components. We incorporated
mechanisms that were highlighted in this study or have previ-
ously shown to be important in cartilage degradation but it has
been constructed in a format that can be readily extended by
ourselves and others as required. Thus, the model is able to
integrate information from different sources and provide a
useful tool for gaining insights into the key mechanisms driving
the age-related changes in cartilage.
Several transcriptomic studies have been performed examin-
ing changes in gene expression in murine OA pathogenesis.36–38
Loeser et al37 showed age-related differences in gene expression
in both sham-operated control and surgically induced OA mice
and demonstrated the importance of ageing in OA animal
model studies confirming the need to study age-related changes
in long-lived mice. Interestingly, another transcriptomic study38
showed that chondrocytes in articular cartilage of OA mice had
similar gene expression profiles with skeletal muscle which was
associated with inappropriate NF-κB signalling, supporting find-
ings from our computational model. The advantage of transcrip-
tomic approaches is that new genes and pathways can be
Figure 6 Computer simulation results obtained from varying three of the model parameters. In each computer experiment, 500 stochastic
simulations were run. (A) Total inhibition of matrix metalloproteinase-13 (MMP-13) synthesis via interleukin-1 pathway (ksynMMP13=0). (B) The
percentage of cells expressing MMP-13 (>15) for the different parameter sets. (C) Total inhibition of MMP-13 synthesis via ALK1 pathway
(ksynMMP13Runx2=0). (D) Increased removal of reactive oxygen species by superoxide dismutase (kremROSBySOD=5e-4/molecules/s). A, B, and D
Output from one randomly selected simulation, black curves show level of collagen II molecules (as a percentage), grey curves show level of MMP-
13. Error bars in B represent a 95% CI of the percentage.
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identified and thus it is possible to examine how gene expres-
sion is affected by nodes in the network. For example, Bateman
et al36 compared profiles from wild-type mice with mice lacking
ADAMTS-5 activity and identified several genes that have an
ADAMTS-5 independent role in OA. Proteomic studies are also
important as changes in protein expression with age do not
always correlate with gene expression although this method is
still fairly new in OA research.39 The disadvantage of ‘omic’
approaches is that it can be difficult to work out the actual
detailed mechanisms involved in initiation and progression of
OA. This highlights the merit of computational models which
are able to examine detailed mechanisms, simulate the temporal
effects of single or multiple interventions and make testable pre-
dictions. Both approaches should be considered complementary
as new information on genes and pathways gathered from tran-
scriptomic and proteomic approaches can be used to modify
and extend the current model.
We have demonstrated that a progressive loss of cartilage
matrix and cellular changes occur with increasing age accom-
panied by an increase in the level of oxidative stress and
MMP-13 in murine articular cartilage. We modelled these
changes using a systems biology approach and demonstrated
that oxidative damage and the IL-1 pathway are pivotal in initi-
ating the changes that lead to the development of disease.
Interestingly, the model predicts that blocking the IL-1 pathway
early in disease is effective at blocking MMP-13 production
while blocking ALK1-mediated MMP-13 production is much
more effective in aged tissues. This finding may have implica-
tions for therapeutic interventions. It would be interesting to
test the model predictions by the use of inhibitors, and the use
of an OA-prone mouse model such as STR/Ort would be ideal
for such future studies.
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